Opportunity Information: Apply for RFA DC 23 001
The NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) funding opportunity (RFA-DC-23-001) is a National Institutes of Health (NIH) grant program that invites applications for R01-level, independent research projects that align with the scientific mission of the National Institute on Deafness and Other Communication Disorders (NIDCD). In practical terms, the FOA is aimed at supporting research that advances knowledge related to hearing, balance, smell, taste, voice, speech, and language, along with the basic, translational, and clinical science that underpins these areas. Because it uses the R01 mechanism, the expectation is that applicants propose a clearly defined, investigator-driven research plan with strong potential for meaningful impact in an NIDCD mission area, and the program allows (but does not require) clinical trial activity, depending on what the science demands.
A central purpose of this announcement is to strengthen and diversify the biomedical and behavioral research workforce by supporting Early Stage Investigators and New Investigators from diverse backgrounds, especially individuals from groups underrepresented in the health-related sciences. The FOA specifically highlights that Principal Investigators from categories A-C of the NIH Diversity Statement (NOT-OD-20-031) are particularly encouraged to apply in coordination with their institutions. This emphasis signals that the program is not only about funding good science, but also about creating a more inclusive pipeline of independently funded researchers in NIDCD-relevant fields, helping new investigators establish themselves and build a trajectory toward long-term research independence.
One notable feature is that preliminary data are not required. That lowers a common barrier for new investigators, especially those who may have had fewer opportunities to build large datasets prior to seeking an R01. Instead, applicants are expected to make a compelling case through strong rationale, sound study design, and clear feasibility, even if the project is at an earlier stage of development. For applicants, this means the proposal should lean heavily on the strength of the hypothesis or conceptual framework, methodological rigor, realistic milestones, and careful attention to potential pitfalls and alternative approaches.
Eligibility is broad across many types of U.S.-based organizations and government entities, reflecting NIH's typical range of applicant institutions. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations (both 501(c)(3) and non-501(c)(3), other than higher education institutions); for-profit organizations other than small businesses; small businesses; public housing authorities and Indian housing authorities; and Native American tribal governments (federally recognized) as well as tribal organizations that are not federally recognized. The FOA also explicitly calls out additional eligible applicant categories that often align with workforce diversity goals and community-serving missions, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISI), along with faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.
At the same time, the FOA draws clear limits around foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed. In effect, the administrative home for the award must be a domestic eligible organization, but the science may still incorporate certain international elements when justified and compliant with NIH policy.
From a funding and administrative standpoint, this is a discretionary grant opportunity in the health category (CFDA 93.173) using the R01 grant mechanism, with clinical trial participation labeled as optional. The listed award ceiling is $500,000 (as provided in the opportunity summary). The original closing date shown for this FOA was August 4, 2023, and the opportunity record indicates it was created on April 5, 2022. Applicants considering similar NIDCD diversity-focused opportunities should pay attention to the specific budget structure and any NIH institute-specific budget guidance in the full FOA text, since R01 budgets can be requested in different formats depending on threshold levels and FOA instructions.
Overall, the program is best understood as an R01 entry point designed to help diverse Early Stage and New Investigators launch independent NIDCD-relevant research programs, with a lowered entry barrier on preliminary data and a wide range of eligible U.S. applicant organizations, while still maintaining standard NIH expectations for significance, innovation, and rigorous, well-justified research design.Apply for RFA DC 23 001
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173.
- This funding opportunity was created on 2022-04-05.
- Applicants must submit their applications by 2023-08-04. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Limited Competition: Research Centers in Minority Institutions (RCMI) Clinical Research Network for Health Equity (UG3/UH3 - Clinical Trial Optional)
Previous opportunity: Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DC 23 001
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DC 23 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 028 Funding Number: RFA AI 22 028 Agency: National Institutes of Health Category: Health Funding Amount: $650,000 |
| Laboratories to Optimize Digital Health (R01 Clinical Trial Required) Apply for PAR 22 154 Funding Number: PAR 22 154 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| A Community Research Resource: Characterization of the Resident Ocular Microbiome. (U24 Clinical Trial Not Allowed) Apply for RFA EY 22 001 Funding Number: RFA EY 22 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Research Centers in Minority Institutions (RCMI) Clinical Research Network for Health Equity (UG3/UH3 - Clinical Trial Optional) Apply for RFA MD 22 006 Funding Number: RFA MD 22 006 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) Apply for RFA RM 22 019 Funding Number: RFA RM 22 019 Agency: National Institutes of Health Category: Health Funding Amount: $900,000 |
| Alcohol Treatment and Recovery Research (R01 Clinical Trial Required) Apply for PAR 22 158 Funding Number: PAR 22 158 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Health Services Research (R34 Clinical Trial Optional) Apply for PAR 22 157 Funding Number: PAR 22 157 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Alcohol Health Services Research (R01 Clinical Trial Optional) Apply for PAR 22 156 Funding Number: PAR 22 156 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Treatment and Recovery Research (R34 Clinical Trial Required) Apply for PAR 22 159 Funding Number: PAR 22 159 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| AHRQ Administrative Supplements for Grants in Health Services Research Apply for PA 22 168 Funding Number: PA 22 168 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Diagnostic Centers of Excellence: Partnerships to Improve Diagnostic Safety and Quality (R18) Apply for RFA HS 22 008 Funding Number: RFA HS 22 008 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $4,000,000 |
| Somatic Cell Genome Editing Program Translational Coordination and Dissemination Center (TCDC) (U24 - Clinical Trial Not Allowed) Apply for RFA RM 22 017 Funding Number: RFA RM 22 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| IND-enabling Studies of Somatic Genome Editing Therapeutic Leads (U19, Clinical Trial Not allowed) Apply for RFA RM 22 015 Funding Number: RFA RM 22 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed) Apply for RFA RM 22 014 Funding Number: RFA RM 22 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Platform Clinical Trials of Genome Editors in Multiple Diseases (UG3/UH3, Clinical Trial Required) Apply for RFA RM 22 016 Funding Number: RFA RM 22 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U01 Clinical Trial Required) Apply for PAR 22 149 Funding Number: PAR 22 149 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| IDeA Clinical Research Resource Center (U24 Clinical Trial Not Allowed) Apply for PAR 22 150 Funding Number: PAR 22 150 Agency: National Institutes of Health Category: Health Funding Amount: $1,800,000 |
| NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional) Apply for RFA RM 22 018 Funding Number: RFA RM 22 018 Agency: National Institutes of Health Category: Health Funding Amount: $700,000 |
| Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed) Apply for RFA AG 23 016 Funding Number: RFA AG 23 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Comprehensive Alcohol Research Centers (P60 Clinical trial Optional) Apply for RFA AA 22 002 Funding Number: RFA AA 22 002 Agency: National Institutes of Health Category: Health Funding Amount: $1,250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DC 23 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
